Work

Real-world experience with sipuleucel-T in patients (pts) ≥80 years old with metastatic castration-resistant prostate cancer (mCRPC): Data from PROCEED.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.6_suppl.131

Authors: Chadi Nabhan, A. Oliver Sartor, Matthew R. Cooperberg, Jeffrey L. Vacirca, Raoul S. Concepcion, William R. Berry, Manish Dhawan, Ronald Tutrone, Andrew Sandler, Candice McCoy, James Boyd Whitmore, Robert Claude Tyler, Celestia S. Higano

Institutions: Advocate Lutheran General Hospital, Oncology Specialists, Tulane University, University of California, San Francisco, Urology Associates, CHRISTUS Highland Medical Center, Chesapeake Urology Associates, Dendreon (United States), University of Washington

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589833135

Cites:

Cited by:

Related to: 10